Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accenture plcACN · Entity 2893 | Grp Chief Exec-Com, Med & Tech | October 22, 2019 | October 24, 2019 |
| Autodesk, Inc.ADSK · Entity 3027 | Director | June 17, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accenture plc
Report date October 22, 2019 · Filed October 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 50,286 |
Ending reported balance
After 2019-10-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-10-22 · Grant · Acquired 17,171 · Balance 58,359 Row 2 · 2019-10-22 · Tax withholding · Disposed 8,073 · Balance 50,286 |
Autodesk, Inc.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,553 |
Reported balance
After 2026-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 1,553 · Balance 1,553 F1: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted automatically upon initial board appointment under the 2022 Equity Incentive Plan and the 2026 Director Compensation Policy, vest on the date of the next annual meeting. F2: The total securities beneficially owned includes 1,553 shares of unvested Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted automatically upon initial board appointment under the 2022 Equity Incentive Plan and the 2026 Director Compensation Policy, vest on the date of the next annual meeting.
F2: The total securities beneficially owned includes 1,553 shares of unvested Restricted Stock Units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ZUORA INC
Report date February 14, 2025 · Filed February 14, 2025
Section 16 reporting ended · disclosed 2025-02-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-14 transaction · row 1
1 source rowRow 1 · 2025-02-14 · Disposition to issuer · Disposed 98,885 · Balance 0 F1: On February 14, 2025 (the "Effective Time"), pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 17, 2024, by and among Zodiac Purchase, L.L.C. ("Parent"), Zodiac Acquisition Sub, Inc. ("Merger Sub") and Zuora (the "Company"), Merger Sub merged with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent. At the Effective Time, each of the Reporting Person's shares of Class A Common Stock (the "Common Stock"), issued and outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive $10.00 per share in cash without interest thereon, and less any applicable tax withholdings (the "Merger Consideration"). F2: Includes unvested restricted stock units ("RSUs") of the Company. Pursuant to the Merger Agreement, at the Effective Time, each of the Reporting Person's RSUs, whether or not vested, outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive cash equal to the product of the number of shares of Common Stock subject to the RSU multiplied by the Merger Consideration (the "Converted RSU Award"). The Converted RSU Award will vest and become payable subject to and in accordance with the same vesting schedule and other terms and conditions applicable to the corresponding RSU immediately prior to the Effective Time, including any acceleration of vesting provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 14, 2025 (the "Effective Time"), pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 17, 2024, by and among Zodiac Purchase, L.L.C. ("Parent"), Zodiac Acquisition Sub, Inc. ("Merger Sub") and Zuora (the "Company"), Merger Sub merged with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent. At the Effective Time, each of the Reporting Person's shares of Class A Common Stock (the "Common Stock"), issued and outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive $10.00 per share in cash without interest thereon, and less any applicable tax withholdings (the "Merger Consideration").
F2: Includes unvested restricted stock units ("RSUs") of the Company. Pursuant to the Merger Agreement, at the Effective Time, each of the Reporting Person's RSUs, whether or not vested, outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive cash equal to the product of the number of shares of Common Stock subject to the RSU multiplied by the Merger Consideration (the "Converted RSU Award"). The Converted RSU Award will vest and become payable subject to and in accordance with the same vesting schedule and other terms and conditions applicable to the corresponding RSU immediately prior to the Effective Time, including any acceleration of vesting provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 22:19 UTC | Autodesk, Inc. ADSK · Entity 3027 | GrantCommon Stock | 1,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001751499-26-000007 · wk-form4_1782166751.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,553 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted automatically upon initial board appointment under the 2022 Equity Incentive Plan and the 2026 Director Compensation Policy, vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 1,553 shares of unvested Restricted Stock Units. Read SEC document |
| February 14, 2025 Filed Feb 14, 2025 16:05 UTC | ZUORA INC ZUO · Entity 16054 | Disposition to issuerClass A Common Stock | 98,885 | $10.00 | $988,850.00 |
DisclosureSEC source: 0001140361-25-004776 · form4.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 14, 2025 (the "Effective Time"), pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 17, 2024, by and among Zodiac Purchase, L.L.C. ("Parent"), Zodiac Acquisition Sub, Inc. ("Merger Sub") and Zuora (the "Company"), Merger Sub merged with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent. At the Effective Time, each of the Reporting Person's shares of Class A Common Stock (the "Common Stock"), issued and outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive $10.00 per share in cash without interest thereon, and less any applicable tax withholdings (the "Merger Consideration"). F2 · shares: Includes unvested restricted stock units ("RSUs") of the Company. Pursuant to the Merger Agreement, at the Effective Time, each of the Reporting Person's RSUs, whether or not vested, outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive cash equal to the product of the number of shares of Common Stock subject to the RSU multiplied by the Merger Consideration (the "Converted RSU Award"). The Converted RSU Award will vest and become payable subject to and in accordance with the same vesting schedule and other terms and conditions applicable to the corresponding RSU immediately prior to the Effective Time, including any acceleration of vesting provisions. F1 · price: On February 14, 2025 (the "Effective Time"), pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 17, 2024, by and among Zodiac Purchase, L.L.C. ("Parent"), Zodiac Acquisition Sub, Inc. ("Merger Sub") and Zuora (the "Company"), Merger Sub merged with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent. At the Effective Time, each of the Reporting Person's shares of Class A Common Stock (the "Common Stock"), issued and outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive $10.00 per share in cash without interest thereon, and less any applicable tax withholdings (the "Merger Consideration"). Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 16:17 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 19,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-24-000177 · wk-form4_1719865018.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,885 F1 · shares: Represents restricted stock units (RSUs) automatically granted at Zuora's Annual Meeting of Stockholders on June 27, 2024. The RSUs will fully vest and convert into shares of Zuora's Class A Common Stock on the earlier of (a) the date of Zuora's 2025 Annual Meeting of Stockholders and (b) the date that is one year following the RSU grant date, subject to continuous service through the vesting date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:04 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 624 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-24-000066 · wk-form4_1709672653.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,655 F1 · shares: Pursuant to Zuora's Non-Employee Director Compensation Program ("Compensation Program"), the Reporting Person previously elected to receive restricted stock units ("RSUs") in lieu of cash compensation for fees payable for services on Zuora's Board of Directors and any committees thereof for fiscal year 2025 ("FY25"). The Compensation Program was subsequently amended to increase FY25 fees. The RSUs granted to the Reporting Person on March 1, 2024, represents the quotient of (i) the increase in the Reporting Person's FY25 compensation fee divided by (ii) the closing price of Zuora's Class A Common Stock on the date of grant. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon vesting. The RSUs vest as to 1/4 of the shares underlying the initial award on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, so long as the Reporting Person continues to provide services to Zuora through each such vesting date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 16:18 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 4,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-24-000058 · wk-form4_1706908721.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,031 F1 · shares: Pursuant to Zuora's Non-Employee Director Compensation Program, the Reporting Person has elected to receive restricted stock units ("RSUs") in lieu of the cash compensation fees payable for services on Zuora's Board of Directors and any committees thereof. The number of RSUs granted to the Reporting Person represents the quotient of (i) all applicable annual retainer fees divided by (ii) the closing price of Zuora's Class A Common Stock on the date of grant. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon vesting. The RSUs vest as to 1/4 of the shares underlying the initial award on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, so long as the Reporting Person continues to provide services to Zuora through each such vesting date. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 19:11 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-24-000014 · wk-form4_1704327104.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,943 F1 · shares: Pursuant to Zuora's Non-Employee Director Compensation Program ("Compensation Program"), the Reporting Person previously elected to receive restricted stock units ("RSUs") in lieu of cash compensation fees payable for services on Zuora's Board of Directors and any committees thereof for fiscal year 2024 ("FY24"). On December 1, 2023, the Reporting Person's compensation fee increased in connection with his appointment as chair of the Nominating and Corporate Governance Committee. The number of RSUs granted to the Reporting Person on January 2, 2023 represents the quotient of (i) the increase in the Reporting Person's compensation fee for FY24 divided by (ii) the closing price of Zuora's Class A Common Stock on the date of grant. The RSUs are fully vested upon grant in accordance with the Compensation Program. Read SEC document |
| June 27, 2023 Filed Jun 27, 2023 20:58 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 16,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-23-000098 · wk-form4_1687913915.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,868 F1 · shares: Represents restricted stock units (RSUs) automatically granted at Zuora's Annual Meeting of Stockholders on June 27, 2023. The RSUs will fully vest and convert into shares of Zuora's Class A Common Stock on the earlier of (a) the date of Zuora's 2024 Annual Meeting of Stockholders and (b) the date that is one year following the RSU grant date, subject to continuous service through the vesting date. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 16:41 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 3,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-23-000024 · wf-form4_167537410186729.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,650 F1 · shares: Pursuant to Zuora's Non-Employee Director Compensation Program, the Reporting Person has elected to receive restricted stock units ("RSUs") in lieu of the cash compensation fees payable for services on Zuora's Board of Directors and any committees thereof. The number of RSUs granted to the Reporting Person represents the quotient of (i) all applicable annual retainer fees divided by (ii) the closing price of Zuora's Class A Common Stock on the date of grant. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon vesting. The RSUs vest as to 1/4 of the shares underlying the initial award on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023, so long as the Reporting Person continues to provide services to Zuora through each such vesting date. Read SEC document |
| June 21, 2022 Filed Jun 24, 2022 19:28 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 19,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-22-000109 · wf-form4_165611331632536.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,665 F1 · shares: Represents restricted stock units (RSUs) automatically granted at Zuora's Annual Meeting of Stockholders on June 21, 2022. The RSUs will fully vest and convert on a one-for-one basis into shares of Zuora's Class A Common Stock on the earlier of (a) the date of Zuora's 2023 Annual Meeting of Stockholders and (b) the date that is one year following the RSU grant date, subject to continuous service through the vesting date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:08 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 2,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-22-000023 · wf-form4_164392251509182.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,243 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Program, the Reporting Person has elected to receive restricted stock units ("RSUs") in lieu of the cash compensation fees payable for services on the Issuer's Board of Directors and any committees thereof. The number of RSUs granted to the Reporting Person represents the quotient of (i) all applicable annual retainer fees divided by (ii) the closing price of the Issuer's Class A Common Stock on the date of grant. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. The RSUs vest as to 1/4 of the shares underlying the initial award on each of March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022, so long as the Reporting Person continues to provide services to the Issuer through each such vesting date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 16:16 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 10,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001423774-21-000057 · wf-form4_162456573891238.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,185 F1 · shares: Reflects Restricted Stock Units (RSUs) automatically granted at the Issuer's Annual Meeting of Stockholders on June 22, 2021. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will fully vest and convert into shares of the Issuer's Class A Common Stock on the earlier of (a) the date of the Issuer's 2022 Annual Meeting of Stockholders and (b) the date that is one year following the RSU grant date, in each case, so long as the Reporting Person continues to provide services to the Issuer through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in the Issuer's 2018 Equity Incentive Plan. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 17:23 UTC | ZUORA INC ZUO · Entity 16054 | GrantClass A Common Stock | 23,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001751499-20-000004 · wf-form4_159553937883046.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,070 F1 · shares: Reflects Restricted Stock Units (RSUs) granted on July 21, 2020, upon the appointment of the Reporting Person to the Issuer's Board of Directors. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of the Issuer's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of July 21, 2021, July 21, 2022, and July 21, 2023, in each case, so long as the Reporting Person continues to provide services to the Issuer through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in the Issuer's 2018 Equity Incentive Plan. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:55 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 8,073 | $185.23 | $1,495,321.43 |
DisclosureSEC source: 0001467373-19-000315 · wf-form4_157195770182219.xml · nonDerivative · entry 2 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,286 Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:55 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 17,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000315 · wf-form4_157195770182219.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,359 Read SEC document |
| October 05, 2019 Filed Oct 8, 2019 20:06 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 25 | $187.96 | $4,699.00 |
DisclosureSEC source: 0001467373-19-000287 · wf-form4_157056515163776.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,188 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 12:09 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 23 | $199.13 | $4,579.88 |
DisclosureSEC source: 0001467373-19-000262 · wf-form4_156803095949635.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,163 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 12:29 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 24 | $187.62 | $4,502.76 |
DisclosureSEC source: 0001467373-19-000247 · wf-form4_156518098360924.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,140 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 20:22 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 25 | $190.00 | $4,749.88 |
DisclosureSEC source: 0001467373-19-000222 · wf-form4_156261731746663.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,116 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 13:08 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 27 | $179.37 | $4,842.99 |
DisclosureSEC source: 0001467373-19-000202 · wf-form4_155991287509271.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,091 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| May 15, 2019 Filed May 17, 2019 13:01 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000178 · wf-form4_155809808027656.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,064 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2019 Filed May 6, 2019 20:10 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 28 | $177.24 | $4,962.68 |
DisclosureSEC source: 0001467373-19-000168 · wf-form4_155717342217737.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,008 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 20:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 28 | $177.73 | $4,976.44 |
DisclosureSEC source: 0001467373-19-000135 · wf-form4_155475507118622.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,980 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 22:22 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 30 | $163.22 | $4,896.45 |
DisclosureSEC source: 0001467373-19-000115 · wf-form4_155191090877223.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,952 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 21:38 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 31 | $156.98 | $4,866.38 |
DisclosureSEC source: 0001467373-19-000083 · wf-form4_154948909947582.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,922 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:16 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 838 | $154.44 | $129,420.72 |
DisclosureSEC source: 0001467373-19-000063 · wf-form4_154940136909676.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,891 Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:36 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 195 | $139.42 | $27,186.90 |
DisclosureSEC source: 0001467373-19-000014 · wf-form4_154695458570214.xml · nonDerivative · entry 3 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,729 Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:36 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000014 · wf-form4_154695458570214.xml · nonDerivative · entry 2 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,924 F2 · shares: Grant made pursuant to the Accenture Voluntary Equity Investment Program. Read SEC document |
| January 05, 2019 Filed Jan 8, 2019 13:36 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 547 | $139.42 | $76,262.74 |
DisclosureSEC source: 0001467373-19-000014 · wf-form4_154695458570214.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,484 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:36 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 2,780 | $140.34 | $390,145.20 |
DisclosureSEC source: 0001467373-19-000001 · wf-form4_154655137482015.xml · nonDerivative · entry 2 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,937 Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:36 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 5,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-19-000001 · wf-form4_154655137482015.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,717 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| December 05, 2018 Filed Dec 6, 2018 21:26 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 28 | $166.23 | $4,654.44 |
DisclosureSEC source: 0001467373-18-000408 · wf-form4_154413154943336.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,373 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:35 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 40 | $161.19 | $6,447.50 |
DisclosureSEC source: 0001467373-18-000397 · wf-form4_154266330721198.xml · nonDerivative · entry 2 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,345 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:35 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000397 · wf-form4_154266330721198.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,385 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 21:14 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 29 | $157.85 | $4,577.51 |
DisclosureSEC source: 0001467373-18-000350 · wf-form4_154153882231611.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,218 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 20:18 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 4,362 | $157.45 | $686,786.00 |
DisclosureSEC source: 0001467373-18-000332 · wf-form4_154049868274138.xml · nonDerivative · entry 2 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,189 Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 20:18 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000332 · wf-form4_154049868274138.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,551 Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 20:15 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 28 | $171.13 | $4,791.64 |
DisclosureSEC source: 0001467373-18-000302 · wf-form4_153911612664383.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,276 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| September 05, 2018 Filed Sep 6, 2018 20:17 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 28 | $168.40 | $4,715.06 |
DisclosureSEC source: 0001467373-18-000279 · wf-form4_153626503782305.xml · nonDerivative · entry 1 Abbosh Omar · CIK 0001751499 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,248 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.